
This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …

Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …

Dr Arthur Roach, Director of Research at the charity Parkinson’s UK, discusses new trials on cannabidiol in the treatment of …

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis …

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around …

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been …

You studied biology at Liverpool John Moores University before heading straight to GSK in 1990 as a Sales Representative; was …

Lung cancer kills more patients than any other variety of cancer, accounting for around a fifth of all cancer-related deaths …

Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s …
Steve Rothberg was blindsided by an AML diagnosis that progressed rapidly with little warning. Ten years later, he discusses his …